Page 3 - Patrick Yu News Today

Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for

20.04.2023 - Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system ... Seite 1

UP Maroons beat NU Bulldogs in Final Four, reach UAAP Finals

Get your holiday presents ready and shop from this leading health and beauty retailer.

Neurology journal BRAIN publishes efficacy and safety results at 1.5-year post treatment BMJ1 Open Ophthalmology publishes characteristics of the ND4-LHON study population before treatment Regulatory

Scientists have created a ‘digital mask’ that will allow facial images to be stored in medical records while preventing potentially sensitive personal biometric information from being extracted and shared.

HEARD IT THROUGH THE GRIPE-VINE: OUR NEW ABNORMAL What kind of individual carbon footprint do you generate with your present lifestyle? At a recent Watsons “Do Good for the Planet” event, this was one of the fun and enlightening interactive elements of the event; as all in attendance were asked to

/PRNewswire/ -- The vast majority of Asian investors see credibility (96%), performance (96%) and service fees (90%) as the key criteria for choosing an asset...

Study is first of its kind to explore the impact of LHON on patients and their relatives in four different countries Study determined that the impact of LHON extends beyond vision-related

Joaqui Manuel caught fire from beyond the arc as De La Salle averted a fourth quarter meltdown to eke out a 76-65 win against National University in the UAAP Season 84 men's basketball tournament at the Mall of Asia Arena in Pasay City Sunday night, May 1. Joaqui Manuel of De La Salle (UAAP Media